Cannabidiol (CBD) Pet Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Pet Type, Distribution Channel, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
CBD Pet Market size was around USD 1.07 Billion in 2026 and is slated to grow at 18.93% CAGR from 2027 to 2036, surpassing USD 6.06 Billion by 2036. The industry revenue for 2027 is assessed at USD 1.25 Billion.
Get more details on this report
Request Free Sample ReportCannabidiol (CBD) Pet Market Intelligence Snapshot
Regional Market Dynamics
- North America held 57.17% in 2026, supported by pet wellness interest, higher companion-animal spending, consumer familiarity, and expanding specialty retail and e-commerce channels.
- Asia Pacific is the fastest-growing region, driven by rising pet ownership, disposable incomes, premium wellness spending, improved product access, and evolving attitudes toward CBD products.
Segment Momentum
- CBD supplements accounted for 60.19% of the market in 2026, driven by strong demand for convenient wellness products such as chews, oils, and treats that support mobility, stress management, and overall pet well-being.
- Pet specialty stores are expanding rapidly as consumers seek expert guidance, curated product selections, and personalized recommendations, boosting confidence in purchasing premium CBD products for pets.
Market Expansion Drivers
- Rising prevalence of chronic pain and anxiety disorders in companion animals
- Increasing pet humanization driving premium wellness product adoption
- Expansion of veterinary CBD formulations improving therapeutic product accessibility
Leading Market Participants
- Prominent players in the CBD pet market include Charlotte's Web Holdings, Inc. (United States), CV Sciences, Inc. (United States), Petco Health and Wellness Company, Inc. (United States), Elixinol Wellness Limited (Australia), CBDfx (United States), Honest Paws, LLC (United States), Canna-Pet LLC (United States), HempMy Pet (United States), Holistapet (United States), King Kanine, LLC (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.07 Billion
- 2027 Estimated Market Size: USD 1.25 Billion
- Projected Market Size: USD 6.06 Billion by 2036
- Growth Forecast: 18.93% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Supplements (Product Type) | Dogs (Pet Type) | E-commerce (Distribution Channel) | Joint Health and Mobility (Application)
- Emerging Opportunity Segment: Supplements (Product Type) | Cats (Pet Type) | Pet Specialty Stores (Distribution Channel) | Pain Management (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic pain and anxiety disorders in companion animals
Growing recognition of chronic pain, mobility challenges, and anxiety-related conditions in companion animals is increasing interest in supportive wellness products designed to improve quality of life. The CBD pet market is expanding as pet owners seek complementary options that may help manage age-related discomfort, stress associated with travel or separation, and other ongoing wellness concerns. This rising awareness encourages greater exploration of specialized pet care products that align with broader preventive health and long-term animal wellbeing practices.
Increasing pet humanization driving premium wellness product adoption
The continued humanization of pets is influencing owners to prioritize high-quality health and wellness products that reflect the level of care provided to other family members. This trend will propel the CBD pet market growth as consumers increasingly invest in premium formulations designed to support the overall wellbeing of companion animals. Purchasing decisions are also shifting toward products that emphasize ingredient quality, transparency, and tailored wellness benefits, reinforcing demand for specialized offerings across the pet care sector.
Expansion of veterinary CBD formulations improving therapeutic product accessibility
The development of veterinary-focused CBD formulations is improving the availability of products specifically designed for companion animal care and wellness applications. In the CBD pet market, purpose-formulated products provide dosing approaches and delivery formats better suited to different animal sizes and species, making them more practical for routine use. Expanding product availability through veterinary-oriented channels also supports broader awareness of specialized wellness options while improving accessibility for pet owners seeking professionally developed care solutions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic pain and anxiety disorders in companion animals | 2% | Moderate | North America, Europe | High | Near Term |
| Increasing pet humanization driving premium wellness product adoption | 1.8% | Low | North America, Asia Pacific | High | Near Term |
| Expansion of veterinary CBD formulations improving therapeutic product accessibility | 1.6% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The cannabidiol (CBD) pet market in North America accounted for the largest share of 57.17% in 2026, supported by growing interest in pet wellness, increasing expenditure on companion animal care, and greater consumer familiarity with cannabidiol-based products. Pet owners are increasingly seeking complementary solutions for issues such as stress, discomfort, and general well-being, creating demand for CBD-infused pet products. Expanding specialty pet retail and e-commerce channels, along with evolving acceptance of plant-based pet wellness products, is further supporting regional market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region in the cannabidiol (CBD) pet market, driven by rising pet ownership, increasing disposable income, and growing attention to companion animal health. Urban households are increasingly treating pets as family members, encouraging greater spending on premium nutrition and wellness products. Improving access to specialized pet-care products through online and modern retail channels is also expanding consumer awareness, while gradual changes in attitudes and regulatory approaches toward cannabidiol-based products are creating additional opportunities across selected markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Veterinary Wellness AdoptionThe U.S. CBD pet market is shaped by expanding premium pet care offerings and growing interest in hemp-derived wellness products for companion animals. Companies emphasize product quality, veterinary engagement, and transparent ingredient sourcing to strengthen consumer confidence.
Germany 🇩🇪
Regulated Product StandardsGermany prioritizes compliance with evolving regulations and scientifically supported product formulations in the CBD pet market. Manufacturers focus on controlled distribution channels and quality assurance to meet expectations from retailers, veterinarians, and pet owners.
Japan 🇯🇵
Functional Pet Care FocusJapan integrates CBD pet products into the broader trend of functional pet wellness, with attention to aging companion animals and daily health support. Brands invest in carefully formulated products that align with consumer preference for safe and premium pet care solutions.
South Korea 🇰🇷
Premium Companion NutritionSouth Korea is expanding premium CBD pet offerings alongside rising demand for specialized nutrition and wellness products. Market participants emphasize innovative formulations, digital retail engagement, and consumer education to encourage responsible product adoption.
France 🇫🇷
Natural Care PositioningFrance favors CBD pet products positioned around natural wellness and responsible ingredient selection. Suppliers work to align product development with evolving regulatory expectations while expanding premium options through specialty pet retail channels.
Italy 🇮🇹
Boutique Wellness ExpansionItaly supports growth in CBD pet products through specialty retailers and premium pet care brands targeting wellness-conscious owners. Companies prioritize product differentiation, trusted sourcing, and educational marketing to encourage wider acceptance.
Segment Leadership and Growth Trends
Cannabidiol (CBD) Pet Market Share (%), by Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Supplements (Largest & Fastest-Growing Segment)
The supplements segment dominated the CBD pet market and accounted for a 60.19% share in 2026 while also emerging as the fastest-growing product category. Its strong position is supported by growing pet owner interest in wellness-focused products designed to promote overall health, mobility, stress management, and general well-being. CBD supplements are available in convenient formulations such as chews, oils, and treats, making them easy to administer as part of daily pet care routines. Rising awareness of preventive pet healthcare, coupled with increasing demand for natural wellness solutions, continues to reinforce the segment's leadership and growth trajectory.
Pet Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
Dogs accounted for the largest market share of 63.6% in 2026 due to their significantly larger representation in companion animal ownership and the increasing use of wellness products to support joint health, anxiety management, and overall quality of life. Pet owners are increasingly incorporating CBD-based products into routine care for dogs, supported by growing awareness of alternative wellness approaches and expanding product availability.
The cats segment is expected to record the fastest growth as awareness of feline health and behavior management continues to increase among pet owners. Demand is rising for products formulated to support stress reduction, mobility, and age-related wellness concerns in cats. The introduction of species-specific formulations and greater product accessibility through specialized retail channels are further contributing to segment expansion.
Distribution Channel Segment Analysis: E-commerce (Largest Segment) vs Pet Specialty Stores (Fastest-Growing Segment)
Holding the largest share of the market in 2026, the e-commerce segment benefited from consumers' preference for convenient purchasing, broad product availability, and easy access to detailed product information. Digital platforms enable pet owners to compare formulations, read customer reviews, and subscribe to recurring purchases, supporting sustained growth in online sales. The expanding penetration of digital commerce continues to reinforce the channel's market leadership.
Pet specialty stores are projected to witness the fastest growth as consumers increasingly seek expert recommendations and personalized guidance when selecting CBD products for pets. These stores provide curated product assortments, knowledgeable staff, and specialized shopping experiences that help build consumer confidence. Growing emphasis on premium pet care products and specialized retail services is expected to accelerate demand through this distribution channel.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Therapeutics, Supplements | Supplements | Supplements |
| Pet Type | Cats, Dogs, Others | Dogs | Cats |
| Distribution Channel | Pet Specialty Stores, CBD Stores, E-commerce, Others | E-commerce | Pet Specialty Stores |
| Application | Pain Management, Anxiety and Stress Relief, Joint Health and Mobility, Skin and Allergies, Others | Joint Health and Mobility | Pain Management |
Competitive Landscape and Market Positioning
Leading companies in the cannabidiol (CBD) pet market:
- Charlotte's Web Holdings, Inc. (United States)
- CV Sciences, Inc. (United States)
- Petco Health and Wellness Company, Inc. (United States)
- Elixinol Wellness Limited (Australia)
- CBDfx (United States)
- Honest Paws LLC (United States)
- Canna-Pet LLC (United States)
- HempMy Pet (United States)
- Holistapet (United States)
- King Kanine LLC (United States)
The Cannabidiol (CBD) Pet Market is evolving toward greater product specialization as manufacturers tailor formulations to different animal types, wellness applications, and methods of administration instead of competing solely through broad product portfolios. Competitive strength increasingly depends on ingredient consistency, transparent sourcing practices, and manufacturing quality that can reinforce confidence among retailers, veterinarians, and pet owners navigating a developing category. As regulatory expectations and consumer scrutiny continue to shape purchasing behavior, companies are investing in quality assurance, formulation refinement, and educational support that differentiate products through credibility as much as perceived efficacy.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Charlotte's Web Holdings Inc. (United States) | |||||||
| CV Sciences Inc. (United States) | |||||||
| Petco Health and Wellness Company Inc. (United States) | |||||||
| Elixinol Wellness Limited (Australia) | |||||||
| CBDfx (United States) | |||||||
| Honest Paws LLC (United States) | |||||||
| Canna-Pet LLC (United States) | |||||||
| HempMy Pet (United States) | |||||||
| Holistapet (United States) | |||||||
| King Kanine LLC (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cannabidiol (CBD) Pet Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Pet Size | Small Pets, Medium-Sized Pets, Large Pets |
| Veterinary Recommendation | Veterinary-Recommended, Owner-Initiated |
| Purchase Purpose | Preventive Care, Therapeutic Support, General Wellness |
Cannabidiol (CBD) Pet Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Adoption and Acceptance Landscape |
|
| Pet Owner Purchase Journey Assessment |
|
| Country-Level Regulatory Readiness Mapping |
|
Need a different cut of the data?
Request Custom ResearchHow much is the cannabidiol (CBD) pet market worth?
How is the cannabidiol pet industry expected to grow over the next 10 years?
How is pet humanization shaping demand for premium CBD wellness products?
How are veterinary-focused CBD formulations improving product accessibility?
Why do CBD supplements lead the CBD pet market?
Why are pet specialty stores the fastest-growing distribution channel?
Why does North America lead the cannabidiol (CBD) pet market?
How is Asia Pacific driving growth in the cannabidiol (CBD) pet market?
What are the key competitors in the cannabidiol pet landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization